7Baggers
Quarterly
Annual
    Unit: USD2024-12-29 2024-03-31 2023-12-31 2023-04-02 2022-01-01 2021-10-03 2021-06-30 2021-03-31 
      
    		        
      cash flows used in operating activities:
    		        
      net income
    		-37,452,000 -46,497,000 -60,038,000 -73,603,000 -10,316,000 128,186,004 -118,139,039 -51,352,965 
      adjustments to reconcile net income to net cash from operating activities
    		        
      depreciation, accretion and amortization
    		7,544,000 24,974,000       
      stock-based compensation
    		10,207,000 12,760,000 11,620,000 29,157,000     
      changes in fair value of common stock warrants
    		 -21,120,000       
      gain on bargain purchase of assets
    		        
      impairment and loss on disposal of long-lived assets
    		9,000        
      interest expense
    		        
      others
    		274,000 173,000       
      changes in operating assets and liabilities:
    		        
      accounts and notes receivables
    		-2,959,000 505,000       
      inventory
    		1,900,000 2,202,000 4,091,000 -181,000     
      prepaid expenses and other assets
    		1,702,000 -1,809,000 -1,172,000 364,000 -1,183,000    
      accounts payable
    		2,048,000 -7,281,000 1,758,000 -1,792,000 2,629,000    
      accrued expenses and compensation
    		-159,000 2,845,000 -1,136,000 3,858,000 -626,000    
      deferred revenue
    		-2,556,000 -1,402,000   -6,381,000    
      deferred tax liability
    		606,000 -222,000       
      other liabilities
    		-2,237,000 -172,000 189,000 -1,000 -498,000    
      net cash from operating activities
    		-15,958,000 -35,044,000 -27,228,000 -25,611,000 -48,226,000 -33,850,011 -173,704 -490,285 
      capex
    		-16,358,000 433,000 -28,816,000 1,708,000 -4,703,000 0 0 0 
      free cash flows
    		-32,316,000 -34,611,000 -56,044,000 -23,903,000 -52,929,000 -33,850,011 -173,704 -490,285 
      cash flows from investing activities:
    		        
      purchase of property and equipment
    		-16,358,000 -15,088,000 -28,816,000 -3,032,000 -4,703,000    
      payment for business acquisition
    		        
      purchases of investments
    		0 -17,066,000 -22,607,000      
      maturities of investments
    		0 51,260,000 50,450,000      
      net cash from investing activities
    		-16,358,000 19,106,000 -10,941,000 -3,032,000 -4,703,000 -31,542,846 11,554 22,292 
      cash flows from financing activities:
    		        
      proceeds from issuance of convertible senior notes and loan borrowing
    		        
      payments of debt issuance costs
    		  -666,000      
      repayment of debt
    		-29,000        
      purchase of capped calls
    		  0      
      proceeds from exercise of common stock warrants
    		        
      payments of issuance costs related to common stock and warrant dividends
    		        
      repurchase of common stock
    		        
      proceeds from the exercise of stock options and issuance of common stock under atm, net of issuance costs
    		        
      payroll tax payments for shares withheld upon vesting of rsus
    		-1,478,000 -2,222,000 -943,000 -777,000     
      proceeds from issuance of common stock under employee stock purchase plan
    		361,000  1,181,000      
      repurchase of unvested restricted common stock
    		0  -3,000 -9,000 3,000    
      net cash from financing activities
    		106,532,000 5,430,000 2,196,000 -457,000 -319,166,000    
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-2,472,000 -541,000       
      change in cash, cash equivalents, and restricted cash
    		71,744,000 -11,049,000 -35,819,000 -29,100,000 -372,095,000    
      cash and cash equivalents and restricted cash, beginning of period
    		0 235,123,000 0 322,976,000 356,200,000    
      cash and cash equivalents and restricted cash, end of period
    		        
      proceeds from loan borrowing
    		 1,800,000       
      payments of transaction costs related to common stock issuance
    		        
      payment of acquisition costs
    		        
      cash and cash equivalents, and restricted cash, end of period
    		71,744,000 224,074,000 -35,819,000 293,876,000 -15,895,000    
      change in fair value of common stock warrants
    		        
      routejade acquisition, net of cash and restricted cash acquired
    		        
      proceeds from issuance of common stock, net of issuance costs
    		        
      proceeds from exercise of common stock warrants, net and convertible preferred stock warrants
    		        
      proceeds from issuance of convertible senior notes and loans
    		        
      proceeds from loan borrowing and issuance of convertible senior notes
    		        
      proceeds from the exercise of stock options and issuance of common stock, net of issuance costs
    		 5,852,000       
      supplemental cash flow disclosure:
    		        
      cash paid for interest
    		 23,000       
      cash paid for income taxes
    		 88,000       
      supplemental non-cash investing and financing activities:
    		        
      purchase of property and equipment included in liabilities
    		 15,521,000  4,740,000     
      change in fair value of common stock warrants and convertible preferred stock warrants
    		        
      impairment of equipment
    		  0      
      proceeds from business combination and pipe financing
    		        
      proceeds from issuance of convertible senior notes and secured promissory note
    		        
      proceeds from the exercise of stock options
    		  2,696,000 329,000 2,216,000    
      cash flows from operating activities:
    		        
      depreciation
    		   3,455,000 6,751,000    
      amortization of right-of-use assets
    		   143,000 159,000    
      accretion of discount on investments
    		        
      amortization of debt issuance costs
    		        
      accounts receivable
    		   149,000     
      deferred contract costs
    		    5,033,000    
      proceeds from issuance of convertible senior notes
    		        
      changes in fair value of convertible preferred stock warrants and common stock warrants
    		   12,840,000 -71,501,000    
      supplemental cash flow data
    		        
      loss on early debt extinguishment
    		        
      payments of transaction costs related to business combination and pipe financing
    		        
      proceeds from secured promissory notes, converted promissory notes and paycheck protection program loan
    		        
      repayment of secured promissory note
    		        
      payment of debt issuance costs
    		        
      proceeds from exercise of convertible preferred stock warrants
    		        
      net liabilities assumed from business combination
    		        
      accrued transaction costs
    		        
      stock-based compensation expense
    		        
      issuance of convertible preferred stock warrants
    		        
      change in fair value of convertible promissory notes
    		        
      gain on early debt extinguishment
    		        
      proceeds from issuance of convertible preferred stock
    		        
      deferred rent
    		        
      accrued purchase of property and equipment
    		        
      accrued purchase of transaction costs
    		        
      conversion of promissory notes to convertible preferred stock
    		        
      settlement of accrued interest expense through conversion of promissory notes to convertible preferred stock
    		        
      adjustments to reconcile net income to net cash from operating activities:
    		        
      change in fair value of warrants
    		      117,485,000 50,845,000 
      interest earned on marketable securities held in trust account
    		      -6,900 -61,910 
      unrealized gain on marketable securities held in trust account
    		      0 -9,455 
      prepaid expenses
    		      44,738 -13,909 
      accounts payable and accrued expenses
    		        
      cash withdrawn from trust account to pay franchise and income taxes
    		        
      net change in cash
    		      -162,150 -467,993 
      cash - beginning of period
    		      0 773,086 
      cash - end of period
    		      -162,150 305,093 
      rsvac common stock shares outstanding prior to the merger
    		        
      less redemption of rsvac common stock shares
    		        
      rsvac common stock shares
    		        
      pipe shares issued
    		        
      merger and pipe shares
    		        
      legacy enovix common shares
    		        
      total shares of common stock immediately after the merger
    		        
      accrued expenses
    		       102,954 
      cash withdrawn from trust account to pay taxes
    		       22,292 
      ·
    		        
      proceeds from paycheck protection program loan
    		        
      gain on extinguishment of the paycheck protection program loan
    		        
      common stock subject to possible redemption
    		        
      numerator: earnings allocable to common stock subject to possible redemption
    		        
      unrealized loss on marketable securities held in trust account
    		        
      net income allocable to shares subject to possible redemption
    		        
      denominator: weighted-average common stock subject to possible redemption
    		        
      basic and diluted weighted-average shares outstanding
    		        
      basic and diluted net income per share
    		        
      non-redeemable common stock
    		        
      numerator: net income minus net earnings
    		        
      net income allocable to common stock subject to possible redemption
    		        
      non-redeemable net income
    		        
      denominator: weighted-average non-redeemable common stock
    		        
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.